Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like How Much Juno Spent on Its Failed CAR-T Drug May 25, 2017 Suitors Line Up for Merck KGaA's $4.7B Consumer Health Biz December 14, 2017 2 Biotech Players to Keep Your Eye On April 20, 2017